Kristin Glab

Kristin Glab currently serves as Associate Director of both Pharmacovigilance Scientist and Pharmacovigilance Operations at Karyopharm Therapeutics Inc., where responsibilities include developing safety profiles for XPO-1 inhibitors, supporting regulatory submissions, ensuring inspection preparedness, and managing a pharmacovigilance case processing team. Prior experience includes various roles at PAREXEL, where Kristin contributed to safety management in clinical trials and collaborated on regulatory reporting for multinational studies. Kristin's earlier positions encompass roles in laboratory logistics and pharmacy internships, contributing to clinical trials and patient care. Educational qualifications include a PharmD from the Massachusetts College of Pharmacy and Health Sciences, a Master's degree in Organic Chemistry from MIT, and a Bachelor's degree in Chemistry from Vanderbilt University, complemented by a postgraduate certificate in Clinical Trial Management from Parexel Academy.